Literature DB >> 29804995

Controlled rapid synthesis and in vivo immunomodulatory effects of LM α(1,6)mannan with an amine linker.

Warunda Bunthitsakda1, Haris Leelayuwapan2, Jiraporn Paha3, Niwat Kangwanrangsan4, Runglawan Chawengkirttikul3, Marisa Ponpuak3, Somsak Ruchirawat5, Siwarutt Boonyarattanakalin6.   

Abstract

The synthetic lipomannan (LM) α(1,6)mannans, already equipped with an amine linker on the reducing end, are rapidly synthesized in a size-, regio-, and stereocontrolled reaction. The size of the mannans is regulated through the concentration of the linker, applied during the controlled ring-opening polymerization reaction. The versatile amine linker enables a variety of glycan conjugations. The synthetic α(1,6)mannans exert adjuvant activities for a real vaccine antigen, tetanus toxoid (TT) in vitro, as demonstrated by the increased secretion of proinflammatory cytokines TNF-α and IL-6 from the treated macrophages. A conjugation of synthetic α(1,6)mannan with TT can also enhance immune response to TT in vivo after immunization as shown by an increase in TNF-α, IFN-γ, and IL-2 production in splenocytes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Controlled polymerization; Glycan conjugation; Lipomannan glycan; Rapid synthesis

Mesh:

Substances:

Year:  2018        PMID: 29804995     DOI: 10.1016/j.carbpol.2018.04.045

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Synthetic Glyconanoparticles Modulate Innate Immunity but Not the Complement System.

Authors:  Chandradhish Ghosh; Patricia Priegue; Harin Leelayuwapan; Felix F Fuchsberger; Christoph Rademacher; Peter H Seeberger
Journal:  ACS Appl Bio Mater       Date:  2022-04-18

Review 2.  Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors.

Authors:  Stefanie Busold; Noémi A Nagy; Sander W Tas; Ronald van Ree; Esther C de Jong; Teunis B H Geijtenbeek
Journal:  Front Immunol       Date:  2020-02-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.